Drug intelligence / Profile preview

glycoursodeoxycholic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

Glycoursodeoxycholic acid (GUDCA) is a glycine-conjugated form of ursodeoxycholic acid. It is an endogenous bile acid metabolite with regulatory effects on bile acid metabolism and gut microbiota. Preclinical studies show that GUDCA supplementation improves metabolic profiles by decreasing blood glucose, ameliorating insulin resistance and hepatic steatosis, and providing hepatoprotective and neuroprotective effects. Mechanistically, GUDCA has been shown to inhibit the intestinal FXR axis, modulate ER stress, suppress apoptosis, and alter the bile acid pool composition, suggesting a role in the management of metabolic disorders such as diabetes and non-alcoholic fatty liver disease[1][2][3][4][5].

Other names
glycoursodeoxycholic acidursodeoxycholylglycineglycine ursodeoxycholic acidglycylursodeoxycholic acidN-(3α,7β-dihydroxy-5β-cholan-24-oyl)glycinePF1G5J2X2APF-1G5J2X2APF 1G5J2X2ACHEBI:89929
02

Targets

FXR (Farnesoid x-activated receptor)

Beyond the preview

Go deeper on glycoursodeoxycholic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycoursodeoxycholic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call